MLYS — Mineralys Therapeutics, Inc. stock price, charts and financials

QT61Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
26.50
+0.72+2.79%
OverviewShort InterestFilings
MLYSQT61Mineralys Therapeutics, Inc.·NASDAQ
26.50+2.79%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 23, 20264Statement of changes in beneficial ownership
Jul 20, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 03, 20268-KCurrent report
May 22, 20268-KCurrent report
May 19, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 21, 20264Statement of changes in beneficial ownership
Apr 15, 20264Statement of changes in beneficial ownership
Apr 15, 20264Statement of changes in beneficial ownership
Apr 13, 20264Statement of changes in beneficial ownership
Apr 10, 2026ARSAnnual report to shareholders
Apr 08, 2026DEF 14ADefinitive proxy statement
Apr 08, 2026DEFA14AAdditional proxy soliciting materials
Apr 02, 20264Statement of changes in beneficial ownership
Apr 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 290
Page
▼
/ 12